David Stack, Pacira CEO
After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
After being acquired by Pacira Biosciences in a $450 million deal, it looks like Flexion Therapeutics quietly brought out the axe.
While details remain few …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.